Search Results 1351-1360 of 16652 for monoclonal antibody
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...
Monoclonal gammopathy of undetermined significance (MGUS) or smoldering myeloma · Prior cytotoxic chemotherapy or corticosteroids for the treatment of multiple ...
Receipt of an investigational immunomodulator or monoclonal antibody within 180 days (or 5 half-lives, whichever is longer) prior to Screening. Receipt of ...
GSK3511294 (long-acting anti-IL-5) in the past 12 months. 5. Treatment with any of the following monoclonal antibody therapies within 120 days prior to ...
... monoclonal antibody; ≥ 2 weeks must have elapsed since local palliative radiation therapy (XRT) (small port); ≥ 6 weeks must have elapsed since treatment ...
In 2004,. Mayo Clinic researchers discovered the antibody NMO-IgG — the first serum biomarker for any form of inflammatory demyelinating brain disease. A year ...
Serum monoclonal protein >= 1.0 g/dL; > 200 mg of monoclonal protein in the ... Monoclonal bone marrow plasmacytosis > 30% (evaluable disease). Prior ...
Prior exposure to immunotherapy such as but not limited to other anti-cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), anti-PD 1, or anti-PD-L1 antibodies ...
... antibodies) treatment, CPI-naïve hepatocellular carcinoma (HCC), and treatment-naïve endometrioid endometrial cancer. A Study to Evaluate the Safety and ...
Mayo Clinic researchers have identified an immune system 'glitch' that reveals people whose immune systems produce too much of an antibody molecule called a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.